Search results
Results from the WOW.Com Content Network
It was developed to assess the quality of life in cancer patients undergoing clinical trials for cancer therapy. Dr. Cella argues for the value of quality of life measures in general because "implicitly, the relief of a symptom is valued because of its associated benefit to patient function and well-being.
The results showed that the full set of proposed quality standards were only met in 28.1% of patients, who were all diagnosed between 2011 and 2014 with non-metastatic rectal cancer. [9] The completion of these measures varied based on location of the facility, type of facility, insurance, race, stage of disease, and operative volume.
Quality of life measuring tools can fail to account for effective therapeutic strategies that can alleviate health burdens, and thus can promote a self-fulfilling prophecy for patients. On a societal level, the concept of low quality of life can also perpetuate negative prejudices experienced by people with disabilities or chronic illnesses. [51]
The data is used to evaluate patient outcome, quality of life, provide follow-up information, calculate survival rates, analyze referral pattern, allocate resources at regional or state level, report cancer incidence as required under state law, and evaluate efficacy of treatment modalities. [3]
Cancer mortality rates are determined by the relationship of a population's health and lifestyle with their healthcare system. In the United States during 2013–2017, the age-adjusted mortality rate for all types of cancer was 189.5/100,000 for males, and 135.7/100,000 for females. [ 1 ]
In medicine (oncology and other fields), performance status is an attempt to quantify cancer patients' general well-being and activities of daily life. This measure is used to determine whether they can receive chemotherapy, whether dose adjustment is necessary, and as a measure for the required intensity of palliative care.
One quality-adjusted life year (QALY) is equal to 1 year of life in perfect health. [2] It combines two different benefits of treatment—length of life and quality of life—into a single number that can be compared across different types of treatments. For example, one year lived in perfect health equates to 1 QALY.
The Recurrent genital herpes quality of life measure (RGHQoL) was developed in 1998 by Galen Research in order to assess the impact recurrent genital herpes has on quality of life. [97] It has been used in clinical trials investigating famciclovir, [98] suppressive antiviral therapy [99] and patient perspectives and quality of life. [100] [101]